Tissue factor pathway inhibitor suppresses the growth of human vascular smooth muscle cells through regulating cell cycle
โ Scribed by Xia Dong; Liping Song; Dunwan Zhu; Hailing Zhang; Lanxia Liu; Xigang Leng
- Book ID
- 106470945
- Publisher
- Springer
- Year
- 2010
- Tongue
- English
- Weight
- 266 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0301-4851
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Smooth muscle cell (SMC) proliferation and migration are key processes that occur in the reparative response to injury after percutaneous coronary intervention and in failed bypass grafts for the treatment of atherosclerosis. In the present study, we generated novel synthetic small inte
The role of nutrient supply in the replicative capacity and secretory phenotype of cultured human diploid cells is unclear. We examined the relationship between amino acid privation, the secretion of vascular endothelial growth factor (VEGF) and growth phenotype of vascular smooth muscle cells (VSMC
Vascular smooth muscle cells (SMC) synthesize insulin-like growth factor-I (ILF-I), which is a mitogen for this cell type in vitro. Since IGF binding proteins (IGFBP) modulate IGF bioactivity, we determined which IGFBPs were secreted by porcine SMC. Porcine SMC secreted 34,000 and 24,000 M, forms of